MedTrace Logo

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

NCT00807547 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2015-12-29

No results posted yet for this study

Summary

Test of pharmacodynamic efficacy and tolerability of a short-time intra-seasonal updosing

Conditions

  • Allergy

Interventions

BIOLOGICAL

Allergy vaccination (Alutard SQ)

Alutard SQ grasses and rye, 8 subcutaneous injections, updosing to 10.000 SQ-U, duration of treatment 50 days

Sponsors & Collaborators

  • ALK-Abelló A/S

    lead INDUSTRY

Principal Investigators

  • Ludger Klimek, MD · Center for Rhinology and Allergology, An den Quellen 10, 65183 Wiesbaden, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-10-31
Completion
2009-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807547 on ClinicalTrials.gov